These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 29437833)

  • 1. Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells.
    Chen XH; Ruan CC; Ge Q; Ma Y; Xu JZ; Zhang ZB; Lin JR; Chen DR; Zhu DL; Gao PJ
    Circ Res; 2018 Mar; 122(7):970-983. PubMed ID: 29437833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
    Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
    Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6.
    He Y; Zou P; Lu J; Lu Y; Yuan S; Zheng X; Liu J; Zeng C; Liu L; Tang L; Fang Z; Hu X; Liu Q; Zhou S
    Circ Res; 2024 Jan; 134(1):9-29. PubMed ID: 38047378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement 5a receptor mediates angiotensin II-induced cardiac inflammation and remodeling.
    Zhang C; Li Y; Wang C; Wu Y; Cui W; Miwa T; Sato S; Li H; Song WC; Du J
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1240-8. PubMed ID: 24743429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH; van der Touw W; Paz-Artal E; Li MO; Heeger PS
    J Exp Med; 2013 Feb; 210(2):257-68. PubMed ID: 23382542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause and FOXP3
    Pollow DP; Uhlorn JA; Sylvester MA; Romero-Aleshire MJ; Uhrlaub JL; Lindsey ML; Nikolich-Zugich J; Brooks HL
    Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H415-H423. PubMed ID: 31099612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-31 Regulates Immunosuppression in Ang II (Angiotensin II)-induced Hypertension by Targeting Ppp6C (Protein Phosphatase 6c).
    Li X; Cai W; Xi W; Sun W; Shen W; Wei T; Chen X; Sun L; Zhou H; Sun Y; Chen W; Gao P; Wang H; Li Q
    Hypertension; 2019 May; 73(5):e14-e24. PubMed ID: 30929511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling.
    Emmerson A; Trevelin SC; Mongue-Din H; Becker PD; Ortiz C; Smyth LA; Peng Q; Elgueta R; Sawyer G; Ivetic A; Lechler RI; Lombardi G; Shah AM
    J Clin Invest; 2018 Jul; 128(7):3088-3101. PubMed ID: 29688896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.
    Strainic MG; Shevach EM; An F; Lin F; Medof ME
    Nat Immunol; 2013 Feb; 14(2):162-71. PubMed ID: 23263555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.
    Barhoumi T; Kasal DA; Li MW; Shbat L; Laurant P; Neves MF; Paradis P; Schiffrin EL
    Hypertension; 2011 Mar; 57(3):469-76. PubMed ID: 21263125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
    Mian MO; Barhoumi T; Briet M; Paradis P; Schiffrin EL
    J Hypertens; 2016 Jan; 34(1):97-108. PubMed ID: 26630215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
    Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
    J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells.
    van der Touw W; Cravedi P; Kwan WH; Paz-Artal E; Merad M; Heeger PS
    J Immunol; 2013 Jun; 190(12):5921-5. PubMed ID: 23690475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.
    Nguyen H; Kuril S; Bastian D; Kim J; Zhang M; Vaena SG; Dany M; Dai M; Heinrichs JL; Daenthanasanmak A; Iamsawat S; Schutt S; Fu J; Wu Y; Fairlie DP; Atkinson C; Ogretmen B; Tomlinson S; Yu XZ
    JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension: Role of C3aR and C5aR in T
    Carney EF
    Nat Rev Nephrol; 2018 Apr; 14(4):214. PubMed ID: 29479081
    [No Abstract]   [Full Text] [Related]  

  • 18. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer.
    Gadwa J; Bickett TE; Darragh LB; Knitz MW; Bhatia S; Piper M; Van Court B; Bhuvane S; Nguyen D; Nangia V; Kleczko EK; Nemenoff RA; Karam SD
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33789881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4
    Iulita MF; Duchemin S; Vallerand D; Barhoumi T; Alvarez F; Istomine R; Laurent C; Youwakim J; Paradis P; Arbour N; Piccirillo CA; Schiffrin EL; Girouard H
    J Am Heart Assoc; 2019 Jan; 8(1):e009372. PubMed ID: 30572753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
    Ramos TN; Wohler JE; Barnum SR
    Neurosci Lett; 2009 Dec; 467(3):234-6. PubMed ID: 19850104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.